Pharmaceutical & Life Sciences

Pharma marketing that
connects to commercial outcomes —
not just reach and frequency.

Pivot Blue works with pharma CMOs to connect fragmented data, activate AI where compliance allows, and prove the commercial value of marketing, without adding complexity or replacing what already exists.

Book a conversation → See our offerings →

The challenges we hear every time

Four problems holding pharma
marketing back right now.

These aren’t generic marketing challenges. They are the specific frustrations of senior pharma marketing leaders trying to drive growth in one of the most complex commercial environments in the world.

Challenge 01

“Our data is fragmented across brands, markets and channels, nobody has a single view of what’s actually working.”

HCP, patient, CRM, media and sales force data all in separate systems. Decisions made in the dark. Marketing unable to connect activity to outcomes or defend spend with any real confidence.

Challenge 02

“We’ve invested heavily in marketing technology but our teams can’t use it, our agencies control it, and we can’t see the value.”

The stack looks impressive on paper. But adoption is low, agencies have become the gatekeepers, and the technology that was supposed to transform marketing is delivering reports, not growth.

Challenge 03

“AI is on every board agenda but compliance, medical-legal review and risk aversion are killing our ability to move fast enough.”

MLR approval cycles, GDPR in healthcare and risk-averse cultures create paralysis. The organisation talks about AI transformation while the team is still manually building campaign reports. There is a path forward, it just requires knowing where AI can move.

Challenge 04

“We’re measuring reach and frequency, but the business wants to know what marketing is actually contributing to revenue.”

Indirect sales models, long HCP decision cycles and restricted data environments make attribution hard. But the CFO is asking, the board is asking, and “reach and frequency” is no longer an acceptable answer.

73%

of pharma CMOs say proving marketing’s commercial impact is their biggest board-level challenge

4.2x

average number of disconnected data platforms a pharma marketing team manages simultaneously

68%

of pharma marketing technology investment is underutilised within 18 months of deployment

How Pivot Blue helps

We don’t implement technology.
We make your entire marketing operation perform.

Pivot Blue works as your growth and transformation partner, connecting the strategy, data, technology, and AI that already exists in your organisation into one operating model that is accountable to commercial outcomes.

We understand pharma’s unique constraints — MLR processes, indirect sales models, HCP engagement rules, and global market complexity. We work within them, not around them.

Ambition

Define what the marketing growth engine is being asked to deliver commercially, across brands, markets and launch priorities, and the trade-offs leadership is prepared to make.

Data

Make HCP, patient, CRM, media and sales-force data answer the commercial questions that matter, so decisions rest on a complete picture rather than a partial one.

Experience

Design HCP and patient journeys around real engagement patterns rather than channel silos or internal org charts.

Platforms

Establish whether Veeva, Salesforce Health Cloud and the wider stack enable the ambition or constrain it, and what should change before more technology is bought.

Team

Make accountability, decision rights and ownership work across brand, medical, commercial and agency partners within pharma’s compliance reality.

Where we typically start

The most relevant engagements
for pharma marketing leaders.

Every engagement is outcome-led and designed around your specific situation, not a fixed programme sold to every client.

Most common starting point

ADEPT Growth Transformation

Redesign how Ambition, Data, Experience, Platforms and Team work together across the brand portfolio — and strengthen the connections that make marketing operate as one growth engine.

Highest impact

360° Data & Audience Strategy

Define HCP, patient and commercial data strategy around the decisions, experiences and growth outcomes it needs to enable — covering audience architecture, identity, measurement and activation requirements.

Across the whole engine

AI Marketing Strategy & Operating Model

Decide where AI should change marketing within your compliance environment, what remains human-led, which tools and models are appropriate, and what has to change around them.

See all offerings → Or talk to us directly →

Pharma marketing thatconnects to commercial outcomes —not just reach and frequency.

Four problems holding pharmamarketing back right now.

We don’t implement technology.We make your entire marketing operation perform.

The most relevant engagementsfor pharma marketing leaders.

Pharma marketing that
connects to commercial outcomes —
not just reach and frequency.

Four problems holding pharma
marketing back right now.

We don’t implement technology.
We make your entire marketing operation perform.

The most relevant engagements
for pharma marketing leaders.